|

Arthritis Clinical Trials in Baltimore, MD

36 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePhase 3<1 mi
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 1<1 mi
The Pericapsular Nerve Block in Total Hip ArthroplastyPhase 4<1 mi
Safety and Effectiveness of the HIT Reverse HRSN/A<1 mi
Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis PainPhase 4<1 mi
Innovations in Genicular Outcomes Registry—<1 mi
Sleep TO Prevent Post-surgical PainN/A<1 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisPhase 2<1 mi
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the KneePhase 2<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPhase 3<1 mi
Primary Subtalar Arthrodesis for Calcaneal FracturesN/A<1 mi
The Myelin Disorders Biorepository Project—<1 mi
RA-PRO PRAGMATIC TRIALPhase 3<1 mi
Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot Versus Single Radius Design for Total Knee ArthroplastyN/A<1 mi
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Phase 2<1 mi
Safety and Efficacy of ABP-745 in Participants With an Acute Gout FlarePhase 29 mi
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 332 mi
Phase 3 Study of Telitacicept in Active Primary Sjögren's DiseasePhase 332 mi
Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions—34 mi
Studies of the Natural History of Rheumatic Diseases—34 mi
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren DiseasePhase 234 mi
The Pathogenesis and Natural History of Sjogren's Disease—34 mi
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis—34 mi
Natural History and Development of Spondyloarthritis—34 mi
Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study—34 mi
Study of Alkaptonuria—34 mi
Characterization of Diseases With Salivary Gland Involvement—34 mi
Use of Corticosteroid in Intraopertive Injections in Total Knee Replacement Surgery.Phase 2/334 mi
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabPhase 336 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—36 mi
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.Phase 336 mi
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions—36 mi
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout ParticipantsPhase 239 mi
Z1 Hip System: Post-Market Clinical Follow Up Study—41 mi
Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency DepartmentPhase 447 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisPhase 248 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.